Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2/3
×
isoquercitrin
×
Clear all
Filters
2
NCT02195232
2021-03-03
CATIQ
Dana-Farber Cancer Institute
Phase 2/3
Completed
64 enrolled
7 charts